医学
肝细胞癌
肝移植
内科学
危险系数
移植
背景(考古学)
甲胎蛋白
比例危险模型
胃肠病学
回顾性队列研究
米兰标准
放射性武器
肝病
外科
置信区间
古生物学
生物
作者
Mayara Regina Galdino-Vasconcelos,Mateus Silva Feijó,Henrique Metzker Ferro,Ana Clara Ramalho Gomes,Maria Eduarda De Almeida Santos,Gustavo de Sousa Arantes Ferreira,Fernando Jorge,Natália Trevizoli,Luiz Gustavo Guedes Diaz,Priscila Brizolla de Campos,Gabriel Oliveira Nunes Caja,Raquel Francine Bundchen Ullmann,Ana Virgínia Ferreira Figueira,Tiago Nóbrega Morato,André Watanabe
标识
DOI:10.1016/j.transproceed.2022.02.065
摘要
Liver transplantation is a unique treatment opportunity for patients with chronic liver disease and hepatocellular carcinoma (HCC). Selection of HCC patients for transplantation was revolutionized by Milan-based criteria, but tumor recurrence and shortage of organs are still a major concern. Nowadays, additional preoperative tumor parameters can help to refine the graft allocation process. The objective of this study was to evaluate the prognostic value and cut-off points of pretransplant serum alpha-fetoprotein (AFP) levels and radiological tumor parameters on liver transplantation outcomes.This is a single-team retrospective cohort of 162 consecutive deceased donor liver transplants (DDLT) with pathologically confirmed HCC. Pretransplant serum AFP levels and radiological tumor parameters were retrieved from a preoperative follow-up. Receiver-operating characteristics (ROC) curves were used to evaluate cut-off points for each outcome. Multivariate Cox regression model was used to assess the predictors of HCC relapse and recipient mortality.Twelve recipients (7.4%) had HCC recurrence after transplantation, with median survival time of 5.8 months. Pretransplant AFP ≥30 ng/mL (hazard ratio [HR]: 13.84, P = .003) and radiological total tumor diameter (TTD) ≥5 cm (HR: 12.89, P = .005) were independent predictors for HCC relapse. Moreover, pretransplant AFP ≥150 ng/mL was independently associated with recipient mortality (HR: 4.45, P = .003).Pretransplant AFP levels and radiological TTD were independently associated with HCC relapse and recipient mortality after DDLT, with different cut-off points predicting different outcomes. These findings may contribute to improving decision-making in the context of liver transplantation for HCC patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI